These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetic services in Canada: the view from Medicare. Clow CL Prog Clin Biol Res; 1982; 103 Pt B():389-98. PubMed ID: 7163233 [No Abstract] [Full Text] [Related]
5. Genetic services: the March of Dimes' role. Raff B Birth Defects Orig Artic Ser; 1990; 26(2):188-95. PubMed ID: 2094513 [No Abstract] [Full Text] [Related]
6. Newborn screening: current status. Arn PH Health Aff (Millwood); 2007; 26(2):559-66. PubMed ID: 17339686 [TBL] [Abstract][Full Text] [Related]
7. Expanded newborn screening for genetic and metabolic disorders: modeling costs and outcomes. Hubbard HB Nurs Econ; 2007; 25(6):345-52. PubMed ID: 18240836 [TBL] [Abstract][Full Text] [Related]
8. Genetic services in the Czech Republic. Kucerová M; Gregor V; Santavý J Eur J Hum Genet; 1997; 5 Suppl 2():58-63. PubMed ID: 9450197 [No Abstract] [Full Text] [Related]
9. [Neonatal screening in Denmark. Status and future perspectives]. Simonsen H; Brandt NJ; Nørgaard-Pedersen B Ugeskr Laeger; 1998 Sep; 160(40):5777-82. PubMed ID: 9782755 [TBL] [Abstract][Full Text] [Related]
10. Genetic services in Ohio. A regional approach. Eaton AP; Ackerman JH; Linyear AS; Sfakianaki E Ohio State Med J; 1978 Oct; 74(10):623-6. PubMed ID: 714341 [No Abstract] [Full Text] [Related]
11. Medical genetics in Japan. Matsuo M Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():9-10. PubMed ID: 8629149 [TBL] [Abstract][Full Text] [Related]
12. [Genetic counseling and prevention of hereditary disorders]. Galjaard H Ned Tijdschr Geneeskd; 1978 Sep; 122(39):1454-7. PubMed ID: 692771 [No Abstract] [Full Text] [Related]
13. Michigan genetics plan: a report on the needs assessment process. Beene-Harris R; Bach JV Health Promot Pract; 2009 Apr; 10(2):201-9. PubMed ID: 19372281 [TBL] [Abstract][Full Text] [Related]
14. The northeastern France birth defects monitoring system. Stoll C Prog Clin Biol Res; 1985; 163B():157-62. PubMed ID: 3983143 [No Abstract] [Full Text] [Related]
15. Newborn screening for genetic disorders. Fernhoff PM Pediatr Clin North Am; 2009 Jun; 56(3):505-13, Table of Contents. PubMed ID: 19501689 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands. van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759 [TBL] [Abstract][Full Text] [Related]
17. Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. Zelner I; Koren G Ther Drug Monit; 2009 Apr; 31(2):170-2. PubMed ID: 19258931 [TBL] [Abstract][Full Text] [Related]
18. Preventive aspects of genetic morbidity: experiences of the Canadian model. Khalifa MM East Mediterr Health J; 1999 Nov; 5(6):1121-8. PubMed ID: 11924099 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of voluntary prenatal and routine newborn HIV screening. AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279876 [No Abstract] [Full Text] [Related]